The PGY2 oncology pharmacy residency program will provide one year of specialized training such that upon completion, the graduate will be prepared to confidently practice as a successful oncology pharmacist in direct-patient care, research, or operational settings, as well as equipped with the knowledge and skills to sit for and obtain board certification.
The PGY2 oncology pharmacy residency is a new program that will be conducted primarily at the Cowell Family Cancer Center and Munson Medical Center. The oncology service line has ample opportunities for exposure to nearly all required patient care activities and those that are not available here will be coordinated with outside facilities to a ensure a complete education is provided.
The resident will participate in both direct and indirect patient care activities as determined by the program with guidance from the American Society of Health-System Pharmacists (ASHP). In doing so, it is the expectation that they will gain exposure and experience in required disease states to practice comprehensive medication management related to malignancies, associated symptoms and supportive care.
The cancer program at Munson is well-established with eight medical oncologists, five radiation oncologists, one gynecologic oncologist, five nurse practitioners, and a physician’s assistant. Cancer services have expanded greatly in recent years, prompting the construction of a new, state-of-the-art facility, which opened in 2016.
The cancer center occupies a three-story building on the medical campus, allowing for multidisciplinary services at one site including but not limited to radiation oncology, laboratory services, infusion, physician offices, research, and a health and wellness suite with integrative services. The infusion suite on the second floor has 43-chairs and a dedicated oncology pharmacy at its center, staffed by six certified pharmacy technicians and seven oncology pharmacists, four of whom are board certified. The oncology pharmacists work closely with the healthcare team to optimize patient care.
ASHP Accreditation status: Pre-candidate
The program will apply for candidate status when the initial resident starts and accreditation would retroactively include this date such that the resident will have an opportunity to graduate from an ASHP-accredited PGY2 program in the first program year
4 Week Core
Inpatient Stem Cell Transplant
Outpatient Infusion Suite I
Outpatient Infusion Suite II
Investigational Drug Service
Possible Electives (more may be available based on resident interests)
Oncology Supportive Care
Oncology Drug Information
Oncology Pharmacy Operations
Oncology Pharmacy Administration
Insurance (health, dental, life, disability)
Travel Stipend: Amount is determined each year for professional leave and may not cover all travel expenses.